186 related articles for article (PubMed ID: 24266877)
1. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
[TBL] [Abstract][Full Text] [Related]
2. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
3. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
[TBL] [Abstract][Full Text] [Related]
4. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
[TBL] [Abstract][Full Text] [Related]
5. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
Ferdaus MZ; McCormick JA
Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
[TBL] [Abstract][Full Text] [Related]
7. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
Murthy M; Kurz T; O'Shaughnessy KM
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
[TBL] [Abstract][Full Text] [Related]
8. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
[TBL] [Abstract][Full Text] [Related]
9. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
[TBL] [Abstract][Full Text] [Related]
10. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
Guo Q; Zhang Y; Jiang GR; Zhang C
Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
[TBL] [Abstract][Full Text] [Related]
11. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
[TBL] [Abstract][Full Text] [Related]
12. Novel
Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
[TBL] [Abstract][Full Text] [Related]
13. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
14. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in Gordon's syndrome: report of two cases carrying novel heterozygous mutations.
Anglani F; Salviati L; Cassina M; Rigato M; Gobbi L; Calò LA
J Nephrol; 2022 Apr; 35(3):859-862. PubMed ID: 34089516
[TBL] [Abstract][Full Text] [Related]
16. Role of KLHL3 and dietary K
Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
[TBL] [Abstract][Full Text] [Related]
17. Hypercalciuria in familial hyperkalemia and hypertension with KLHL3 mutations.
Mayan H; Carmon V; Oleinikov K; London S; Halevy R; Holtzman EJ; Tenenbaum-Rakover Y; Farfel Z; Hanukoglu A
Nephron; 2015; 130(1):59-65. PubMed ID: 25925082
[TBL] [Abstract][Full Text] [Related]
18. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.
Schumacher FR; Sorrell FJ; Alessi DR; Bullock AN; Kurz T
Biochem J; 2014 Jun; 460(2):237-46. PubMed ID: 24641320
[TBL] [Abstract][Full Text] [Related]
19. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
[TBL] [Abstract][Full Text] [Related]
20. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life.
Etges A; Hellmig N; Walenda G; Haddad BG; Machtens JP; Morosan T; Rump LC; Scholl UI
Nephron; 2022; 146(4):418-428. PubMed ID: 35093948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
